Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TLR2 | O60603 | 1/20 | 0.58 |
| ▸ | SLC6A5 | Q9Y345 | 1/20 | 0.56 |
| ▸ | NMT1 | P30419 | 6/20 | 0.56 |
| ▸ | NMT2 | O60551 | 5/20 | 0.56 |
| ▸ | CTSL | P07711 | 1/20 | 0.52 |
| ▸ | SIRT6 | Q8N6T7 | 1/20 | 0.48 |
| ▸ | SIRT1 | Q96EB6 | 1/20 | 0.48 |
| ▸ | NOD1 | Q9Y239 | 3/20 | 0.47 |
| ▸ | FURIN | P09958 | 3/20 | 0.45 |
| ▸ | FAAH | O00519 | 2/20 | 0.45 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10046363 | 0.95 | TLR2 (0.64) | TLR2SLC6A5NMT1NMT2CTSL | |
| SCHEMBL30340084 | 0.95 | TLR2 (0.64) | TLR2SLC6A5NMT1NMT2CTSL | |
| SCHEMBL30340310 | 0.91 | TLR2 (0.54) | TLR2SLC6A5NMT1NMT2CTSL | |
| SCHEMBL30340165 | 0.91 | SLC6A5 (0.69) | TLR2SLC6A5NMT1NMT2CTSL | |
| SCHEMBL30286903 | 0.90 | TLR2 (0.59) | TLR2SLC6A5NMT1NMT2CTSL | |
| SCHEMBL28354912 | 0.90 | TLR2 (0.59) | TLR2SLC6A5NMT1NMT2CTSL | |
| SCHEMBL29458673 | 0.90 | TLR2 (0.59) | TLR2SLC6A5NMT1NMT2CTSL | |
| SCHEMBL30340265 | 0.89 | SLC6A5 (0.63) | TLR2SLC6A5NMT1NMT2CTSL | |
| SCHEMBL10046476 | 0.89 | TLR2 (0.70) | TLR2SLC6A5NMT1NMT2CTSL | |
| SCHEMBL31518823 | 0.87 | TLR2 (0.58) | TLR2SLC6A5NMT1NMT2CTSL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4622671-A1 | NANOPARTICLE DISPERSIONS COMPRISING THERAPEUTIC AGENTS | Morrison, Eric (US) | 2025-10-01 | — | — | EP | disclosed |
| WO-2024112807-A1 | NANOPARTICLE DISPERSIONS COMPRISING THERAPEUTIC AGENTS | MORRISON Eric (US) | 2024-05-30 | — | — | WO | disclosed |